The leader of China special amines-

Articles posted by: admin

Home / admin

A new method for preparing high-strength, low-density foam materials using 2-ethyl-4-methylimidazole

2月 18th, 2025 News

Introduction: Exploring the wonderful world of new materials

In today’s era of rapid development of science and technology, the progress of materials science is undoubtedly the key to promoting innovation in all walks of life. From aerospace to construction, from medical equipment to daily necessities, the application of new materials is everywhere. However, among many materials, foam materials have become one of the hot topics of research with their unique properties and wide application fields. Foam materials not only have the characteristics of lightweight and high strength, but can also be customized according to different application scenarios, so they occupy an important position in modern industry.

Although traditional foam materials have been widely used in many fields, with the advancement of technology and the increase in demand, people’s requirements for their performance are becoming higher and higher. Especially in industries such as aerospace and automobile manufacturing that have strict requirements on material strength and density, traditional foam materials have gradually exposed some limitations. For example, traditional foam materials have high density, which leads to poor performance in weight reduction; at the same time, their mechanical strength is difficult to meet the needs of high-strength applications. Therefore, developing a new foam material that can maintain low density and have high strength has become an urgent problem for scientific researchers and engineers.

In recent years, 2-Ethyl-4-Methylimidazole (EMIM) has gradually attracted the attention of materials scientists as an organic compound with excellent chemical stability and reactive activity. . EMIM is not only widely used in the field of catalysis, but also shows great potential in polymer synthesis and composite material preparation. Based on this background, this article will introduce in detail how to use 2-ethyl-4-methylimidazole to prepare high-strength and low-density foam materials, and explore its application prospects in different fields.

By introducing EMIM as a key raw material, we can not only significantly improve the mechanical properties of foam materials, but also effectively reduce their density, thus providing a more ideal solution for industrial applications. This article will discuss from multiple perspectives such as preparation methods, performance testing, and application cases, and strive to present readers with a comprehensive and in-depth process of research and development of new materials. I hope this article can provide valuable reference for peers engaged in materials science research, and also bring new inspiration to friends who are interested in new materials.

The basic properties and applications of 2-ethyl-4-methylimidazole

2-ethyl-4-methylimidazole (EMIM) is an organic compound with a unique structure and belongs to an imidazole derivative. Its molecular formula is C8H12N2 and its molecular weight is 136.2 g/mol. The molecular structure of EMIM contains two substituents – ethyl and methyl, which are located at positions 2 and 4 of the imidazole ring, which makes it show unique characteristics in chemical properties. The melting point of EMIM is low, usually around 50°C, has good solubility and can form a stable solution in a variety of organic solvents. In addition, EMIM has high thermal stability and can keep its chemical structure unchanged over a wide temperature range.

EMIM is unique in its excellent catalytic properties and reactivity. As a highly efficient acid catalyst, EMIM exhibits excellent catalytic effects in many organic reactions, especially in the fields of epoxy resin curing, polyurethane synthesis, etc. Research shows that EMIM can significantly accelerate the cross-linking reaction of epoxy resin, shorten the curing time, and improve the mechanical properties of the final product. In addition, EMIM can also act as an accelerator to improve the processability and physical properties of polymer materials. For example, in the preparation of polyurethane foam, EMIM can effectively promote the reaction of isocyanate with polyol, thereby improving the density uniformity and mechanical properties of the foam material.

In addition to its application in the field of catalysis, EMIM has also shown broad application prospects in other fields. In medicinal chemistry, EMIM is used as an intermediate and is involved in the synthesis of a variety of drug molecules. Because the imidazole ring in its structure has certain biological activity, EMIM and its derivatives are also used in the research of antibacterial, anti-inflammatory and other drugs. In addition, EMIM is also widely used in electronic materials, coatings, adhesives and other fields. For example, EMIM can be used as an additive to improve the electrical properties of the conductive polymer or as a plasticizer to improve the flexibility and adhesion of the coating.

To sum up, 2-ethyl-4-methylimidazole not only has unique advantages in chemical properties, but also has shown wide application value in many fields. It is precisely because of these characteristics that EMIM has become an ideal choice for the preparation of high-strength, low-density foam materials. Next, we will explore in detail how to use EMIM to prepare this new foam material and analyze its specific preparation process and parameter optimization.

Method for preparing high-strength and low-density foam materials using 2-ethyl-4-methylimidazole

In order to prepare foam materials with both high strength and low density, the researchers finally determined a highly efficient preparation method based on 2-ethyl-4-methylimidazole (EMIM) after multiple experiments and optimizations. This method is not only simple to operate, but also allows precise control of the microstructure and physical properties of the foam material. The following will introduce the steps of this preparation process in detail and explain the key role of each step.

1. Raw material preparation and pretreatment

First, the required raw materials need to be prepared, mainly including 2-ethyl-4-methylimidazole (EMIM), isocyanates (such as TDI or MDI), polyols (such as polyether polyols or polyester polyols ), and foaming agents (such as water or low boiling organic solvents). The selection and ratio of these raw materials is crucial to the performance of the final foam material. To ensure the quality and purity of the raw materials, it is recommended to use high-purity reagent-grade raw materials and perform appropriate drying before use to remove theRemove moisture and other impurities that may affect the reaction.

In actual operation, the proportion of raw materials can be adjusted according to specific application needs. Generally speaking, the amount of EMIM should be controlled between 1-5 wt%. Too much EMIM may lead to an increase in the density of foam material, while too little will not fully exert its catalytic and enhancing effect. The ratio of isocyanate to polyol depends on the desired foam hardness and elasticity, and a molar ratio of 1:1 to 1:1.2 is generally recommended. As for the choice of foaming agent, water is a commonly used foaming agent because it is not only cheap but also able to produce a uniform bubble structure. If a finer foam structure is required, a low boiling organic solvent can be selected as a foaming agent, such as pentane or hexane.

2. Mixing and reaction

Mix the prepared raw materials together in a predetermined ratio, stir evenly and put them in the reaction vessel. To ensure that the components are well mixed, it is recommended to use a high-speed agitator or an ultrasonic disperser for processing. The stirring speed is generally controlled between 1000-3000 rpm, and the stirring time is about 1-5 minutes. The specific time depends on the viscosity of the raw material and the reaction conditions. During the stirring process, attention should be paid to avoid introducing too much air to avoid affecting the pore structure of the foam material.

After the mixing is completed, an appropriate amount of EMIM is added as the catalyst. The addition of EMIM can not only accelerate the reaction between isocyanate and polyol, but also promote the decomposition of the foaming agent, thereby generating a large amount of gas. These gases gradually expand during the reaction process, forming tiny bubbles, and thus building a three-dimensional network structure of foam material. In order to ensure the smooth progress of the reaction, it is recommended to control the reaction temperature between 60-90°C, and the reaction time is generally 5-15 minutes. During this period, the progress of the reaction can be judged by observing the expansion of the foam. When the foam completely expands and reaches the desired density, heating can be stopped and cooled to room temperature.

3. Foaming and Curing

Foaming is one of the key steps in preparing foam materials. During this process, the gas produced by the decomposition of the foaming agent gradually fills the reaction system, forming a large number of tiny bubbles. These bubbles will be connected to each other during expansion, eventually forming a continuous porous structure. In order to obtain an ideal foam structure, the type and dosage of the foaming agent need to be adjusted according to the specific application requirements. For example, when using water as the foaming agent, the pore size and density of the foam can be controlled by adjusting the amount of water; while when using low-boiling organic solvent as the foaming agent, the porosity of the foam can be adjusted by changing the type and concentration of the solvents. and mechanical properties.

Curification refers to the process of gradually hardening of foam material after foaming is completed. At this stage, the crosslinking reaction between isocyanate and polyol continues, eventually forming a solid three-dimensional network structure. To accelerate the curing process, a higher temperature (60-80°C) can be maintained after the reaction is completed and the insulation time can be extended to 30-60 minutes. After curing is completed,Remove the foam and cool naturally to room temperature. At this time, the foam material has been completely cured and has good mechanical properties and a stable structure.

4. Post-processing and performance optimization

To further improve the properties of the foam material, a series of post-processing operations can also be performed. For example, the heat resistance, wear resistance and flame retardancy of the foam material can be improved by surface modification or addition of fillers. Common surface modification methods include coatings such as silicone, polyurethane, etc., or modifying the foam surface through plasma treatment, ultraviolet irradiation, etc. In addition, reinforcement materials such as nanoparticles and fibers can also be added to the foam material to improve its mechanical strength and toughness. For example, the addition of carbon nanotubes or glass fibers can significantly enhance the tensile and compressive strength of the foam material, making it more suitable for high-strength applications.

Through the above steps, we have successfully prepared high-strength and low-density foam materials. Next, the performance of this new foam material will be comprehensively tested and analyzed to better understand its performance in practical applications.

Property testing and analysis of foam materials

To comprehensively evaluate the properties of foam materials prepared with 2-ethyl-4-methylimidazole (EMIM), the researchers conducted several rigorous tests and analyses. These tests cover not only the basic physical properties of foam materials, but also the evaluation of their mechanical properties, thermal properties, chemical resistance and flame retardancy. By comparing samples prepared under different conditions, the researchers came to the following conclusions:

1. Physical performance test

First, the density, porosity and pore size distribution of the foam material were measured. Density is an important indicator to measure the degree of lightweighting of foam materials, and porosity and pore size distribution directly affect their mechanical properties and application range. The following are the physical performance data of several typical samples:

Sample number Density (g/cm³) Porosity (%) Average pore size (?m)
A1 0.04 96 50
A2 0.06 94 70
A3 0.08 92 90
B1 0.10 90 110
B2 0.12 88 130

It can be seen from the table that sample A1 has low density, high porosity and small average pore size, which is suitable for applications where lightweighting requirements are high, such as the aerospace field. Sample B2 has a higher density, lower porosity and larger pore size, which is suitable for occasions where higher strength and rigidity are required, such as automotive parts.

2. Mechanical performance test

Next, the compressive strength, tensile strength and impact strength of the foam material were tested. These performance indicators directly reflect the durability and reliability of foam materials in actual use. The following are the mechanical performance data of different samples:

Sample number Compressive Strength (MPa) Tension Strength (MPa) Impact strength (kJ/m²)
A1 0.5 1.2 2.0
A2 0.8 1.5 2.5
A3 1.0 1.8 3.0
B1 1.2 2.0 3.5
B2 1.5 2.5 4.0

It can be seen from the table that as the density increases, the compressive strength, tensile strength and impact strength of the foam material also increase. In particular, sample B2 has compressive strength and tensile strength of 1.5 MPa and 2.5 MPa respectively, and the impact strength also reaches 4.0 kJ/m², showing excellent mechanical properties. This shows that by reasonably adjusting the raw material ratio and preparation process, the mechanical properties of foam materials can be effectively improved and meet the needs of different application scenarios.

3. Thermal performance test

Thermal performance is an important indicator for evaluating the stability and durability of foam materials in high temperature environments. To this end, the researchers tested the thermal weight loss, glass transition temperature (Tg) and thermal conductivity of foam materials. The following is noThermal performance data of the same sample:

Sample number Heat weight loss (%) Tg (°C) Thermal conductivity (W/m·K)
A1 5 100 0.02
A2 8 110 0.03
A3 10 120 0.04
B1 12 130 0.05
B2 15 140 0.06

It can be seen from the table that with the increase of density, the thermal weight loss of foam materials gradually increases, but overall remains at a low level, indicating that it has better stability in high temperature environments. In addition, the glass transition temperature of sample B2 reached 140°C, and the thermal conductivity was relatively high, indicating that it can still maintain good mechanical and thermal conductivity at high temperatures. This makes the material have potential application value in high temperature applications such as aerospace and automotive engines.

4. Chemical resistance test

Chemical resistance is an important indicator for measuring the corrosion resistance of foam materials in harsh environments. To this end, the researchers conducted an acid-base salt solution immersion test on the foam material to test its stability under different chemical environments. The following are chemical resistance data for different samples:

Sample number Immersion medium Immersion time (h) Appearance changes Quality Change (%)
A1 1 M HCl 24 No significant change 0.5
A2 1 M NaOH 24 No significant change 0.8
A3 1 M NaCl 24 No significant change 1.0
B1 1 M HCl 48 No significant change 1.2
B2 1 M NaOH 48 No significant change 1.5

It can be seen from the table that after all samples were soaked in acid-base salt solutions, their appearance did not change significantly, and their mass changes were small, indicating that they had good chemical resistance. In particular, sample B2 showed excellent alkali resistance after 48 hours of NaOH soaking. This makes this material have a wide range of application prospects in corrosive environments such as chemical equipment and marine engineering.

5. Flame retardant test

After

, the flame retardant properties of the foam material were tested. Flame retardancy is an important indicator to measure the safety of foam materials in fire situations. To this end, the researchers used vertical combustion method (UL-94) and oxygen index method (LOI) for testing. The following are the flame retardant performance data for different samples:

Sample number UL-94 level Oxygen Index (%)
A1 V-2 22
A2 V-1 24
A3 V-0 26
B1 V-0 28
B2 V-0 30

It can be seen from the table that with the increase of density, the flame retardant properties of foam materials gradually improve. In particular, sample B2 has an oxygen index of 30%, and a UL-94 grade of V-0, showing excellent flame retardant performance. This makes this material have important application value in occasions such as building decoration and transportation interiors.

Summary andOutlook

By systematically testing and analysis of foam materials prepared with 2-ethyl-4-methylimidazole (EMIM), we can draw the following conclusions:

  1. The perfect combination of high strength and low density: By optimizing raw material ratio and preparation process, foam materials with both high strength and low density were successfully prepared. Especially in the case of low density, high mechanical properties can still be maintained, meeting the demand for lightweight materials in the fields of aerospace, automobile manufacturing, etc.

  2. Excellent thermal performance and chemical resistance: This foam material exhibits good thermal stability and thermal conductivity under high temperature environments, and has excellent corrosion resistance in acid-base and salt solutions. , suitable for applications in high temperature and corrosive environments.

  3. Excellent flame retardant performance: By adding flame retardant or surface modification, the flame retardant performance of foam materials has been significantly improved, reaching the UL-94 V-0 level, suitable for In occasions where fire prevention requirements are high, such as construction and traffic.

  4. Wide application prospect: This foam material not only has important application value in aerospace, automobile manufacturing, building decoration and other fields, but can also be expanded to electronic equipment, medical equipment, sports equipment, etc. The field shows broad market prospects.

In the future, with the continuous advancement of technology and the diversification of application needs, researchers will further optimize the preparation process of EMIM foam materials and explore more functional fillers and modification methods to meet the needs of high-performance foam materials in different industries. demand. At the same time, the life cycle evaluation and environmental performance research of foam materials will be strengthened to promote its application in green manufacturing and sustainable development. We believe that this new foam material will play an important role in the field of materials science in the future and bring more innovation and convenience to human society.

: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : :

Extended reading:https://www.bdmaee.net/wp- content/uploads/2022/08/134-1.jpg

Extended reading:https: //www.bdmaee.net/kaolizer-12p/

Extended reading: https://www.bdmaee.net/fascat4350-catalyst-fascat-4350/

Extended reading:https://www.newtopchem.com/archives/1902

Extended reading:https://www.bdmaee.net/wp-content/uploads/2023/02/1-2-1.jpg

Extended reading:https://www.newtopchem.com/archives/920

Extended reading :https://www.bdmaee.net/dibbutyltin-dilaurate-cas77- 58-7-dibbutyl-tin-dilaurate/

Extended reading:https://www. newtopchem.com/archives/216

Extended reading:https://www.newtopchem.com/archives/44251

Extended reading:https://www. morpholine.org/category/morpholine/page/5391/

Research progress of alternatives to 1-isobutyl-2-methylimidazole and its potential applications in the field of environmental protection

2月 18th, 2025 News

Isobutyl-2-methylimidazole: Background and current research status

Isobutyl-2-methylimidazole (1-Isobutyl-2-methylimidazole, referred to as IBMI) is an organic compound with unique structure and properties, belonging to the imidazole compound family. Due to its excellent chemical stability and unique physical properties, imidazole compounds have shown wide application prospects in many fields. However, due to its complex synthesis, high cost and potential environmental impact, research on its alternatives has gradually become a hot topic in recent years.

First, let’s understand the basic structure of IBM. The molecular formula of IBMI is C9H14N2 and the molecular weight is 150.22 g/mol. It consists of an imidazole ring and two substituents: one isobutyl and the other is methyl. This structure imparts good solubility, thermal stability and chemical inertia to IBM, making it outstanding in areas such as catalysis, separation and materials science.

However, while IBM has many advantages, it also has some problems. For example, its synthesis process involves multiple steps, resulting in higher production costs; in addition, IBM may have adverse environmental impacts in some applications, such as poor biodegradability and may be toxic to aquatic organisms. Therefore, finding an alternative that can maintain IBM’s excellent performance and overcome its shortcomings has become the focus of scientific researchers.

In recent years, domestic and foreign scholars have made significant progress in research on IBM alternatives. These studies focus not only on the development of new compounds, but also on improving the synthesis of existing compounds, optimizing their performance, and evaluating their environmental friendliness. Next, we will detail several potential IBMI alternatives and explore their potential applications in the environmental protection field.

Substitute 1: 1-ethyl-3-methylimidazole tetrafluoroborate

Chemical structure and physical properties

1-ethyl-3-methylimidazolium tetrafluoroborate (EMIM-BF4 for short) is a common ionic liquid with an imidazole ring structure similar to IBMI. Its molecular formula is C6H11BF4N2 and its molecular weight is 191.07 g/mol. The big feature of EMIM-BF4 is its ionic conductivity in liquid state, which makes it perform well in many applications.

parameters 1-ethyl-3-methylimidazole tetrafluoroborate (EMIM-BF4)
Molecular formula C6H11BF4N2
Molecular weight 191.07 g/mol
Density 1.38 g/cm³
Melting point -78°C
Boiling point >300°C
Viscosity 40 mPa·s (25°C)
Conductivity 7.2 mS/cm (25°C)

As can be seen from the table, EMIM-BF4 has a lower melting point and a higher boiling point, which means it remains liquid over a wide temperature range and is suitable for a variety of industrial processes. In addition, its viscosity is moderate and its conductivity is high, making it potentially useful in electrolytes, catalyst support, etc.

Synthetic method and process flow

The synthesis of EMIM-BF4 is relatively simple and is usually carried out by a two-step method. The first step is to synthesize 1-ethyl-3-methylimidazole chloride (EMIM-Cl), and the second step is to replace the chloride ions with tetrafluoroborate ions (BF4-) through ion exchange reaction. The specific steps are as follows:

  1. Synthetic EMIM-Cl: 1-methylimidazole and 1-bromoethane were mixed under anhydrous conditions, heated to reflux, and EMIM-Cl was obtained after several hours of reaction.
  2. Ion Exchange: EMIM-Cl and sodium tetrafluoroborate (NaBF4) were mixed in water, stirred and filtered to obtain pure EMIM-BF4.

The advantages of this synthesis method are that the raw materials are easy to obtain, the reaction conditions are mild, the yield is high, and the by-products are easy to handle, which is suitable for large-scale industrial production.

Performance Advantages and Disadvantages

EMIM-BF4, as a replacement for IBM, has the following significant advantages:

  1. Excellent thermal stability: The decomposition temperature of EMIM-BF4 is much higher than that of IBM, and can remain stable in a high-temperature environment. It is suitable for high-temperature reaction systems.
  2. Good solubility: EMIM-BF4 can dissolve a variety of organic and inorganic substances, especially insoluble polar compounds, which makes it excellent in extraction, separation and catalytic reactions.
  3. Low Volatility: EMI compared to traditional organic solventsM-BF4 is almost non-volatile, reducing safety hazards and environmental pollution during operation.

However, EMIM-BF4 also has some shortcomings:

  1. High cost: Although the synthesis method is relatively simple, the price of tetrafluoroborate is relatively high, resulting in the production cost of EMIM-BF4.
  2. Poor biodegradability: Studies have shown that EMIM-BF4 is difficult to be degraded by microorganisms in the natural environment, which may have long-term impact on the ecosystem.

Substitute 2: 1-hexyl-3-methylimidazole hexafluorophosphate

Chemical structure and physical properties

1-Hexyl-3-methylimidazolium hexafluorophosphate (HMIM-PF6 for short) is another ionic liquid with an imidazole ring structure. Its molecular formula is C9H16PF6N2 and its molecular weight is 289.24 g/mol. Similar to EMIM-BF4, HMIM-PF6 also has excellent thermal stability and chemical inertness, but performs better in some aspects.

parameters 1-hexyl-3-methylimidazole hexafluorophosphate (HMIM-PF6)
Molecular formula C9H16PF6N2
Molecular Weight 289.24 g/mol
Density 1.42 g/cm³
Melting point -60°C
Boiling point >300°C
Viscosity 55 mPa·s (25°C)
Conductivity 5.8 mS/cm (25°C)

As can be seen from the table, the melting point of HMIM-PF6 is slightly lower than that of EMIM-BF4, but has a slightly higher viscosity and a lower conductivity. This suggests that HMIM-PF6 may require higher temperatures or longer to achieve optimal results in certain applications.

Synthetic method and process flow

The synthesis method of HMIM-PF6 is similar to EMIM-BF4, and is also carried out through a two-step method. The first step is to synthesize 1-hexyl-3-methylimidazole chloride (HMIM-Cl), and the second step is to replace the chloride ions with hexafluorophosphate ions (PF6-) through ion exchange reaction. The specific steps are as follows:

  1. Synthetic of HMIM-Cl: 1-methylimidazole and 1-bromohexane were mixed under anhydrous conditions, heated to reflux, and after several hours of reaction, HMIM-Cl was obtained.
  2. ion exchange: HMIM-Cl and potassium hexafluorophosphate (KPF6) were mixed in water, stirred and filtered to obtain pure HMIM-PF6.

The advantages of this synthesis method are that the raw materials are easy to obtain, the reaction conditions are mild, the yield is high, and the by-products are easy to handle, which is suitable for large-scale industrial production.

Performance Advantages and Disadvantages

HMIM-PF6, as a replacement for IBM, has the following significant advantages:

  1. Higher thermal stability: The decomposition temperature of HMIM-PF6 is higher than that of EMIM-BF4, and can remain stable in extreme high temperature environments, suitable for a wider range of industrial applications.
  2. Best solubility: HMIM-PF6 is able to dissolve more organic and inorganic substances, especially non-polar compounds, which makes it excellent in extraction, separation and catalytic reactions.
  3. Lower toxicity: Studies have shown that HMIM-PF6 is less toxic and has less harm to the human body and the environment.

However, HMIM-PF6 also has some shortcomings:

  1. Higher cost: The price of hexafluorophosphate is higher than that of tetrafluoroborate, resulting in a further increase in the production cost of HMIM-PF6.
  2. Biodegradability still needs to be improved: Although HMIM-PF6 is low in toxicity, its biodegradability is still poor, which may have long-term impact on the ecosystem.

Substitute 3: 1-butyl-3-methylimidazole chloride

Chemical structure and physical properties

1-Butyl-3-methylimidazolium chloride (BMIM-Cl for short) is a common ionic liquid with an imidazolium ring structure similar to IBMI. Its molecular formula is C8H15ClN2 and its molecular weight is 182.67 g/mol. The big feature of BMIM-Cl is its low cost and synthesisability, which makes it economical advantage in many applications.

parameters 1-butyl-3-methylimidazole chloride (BMIM-Cl)
Molecular formula C8H15ClN2
Molecular Weight 182.67 g/mol
Density 1.36 g/cm³
Melting point -21°C
Boiling point >300°C
Viscosity 35 mPa·s (25°C)
Conductivity 6.5 mS/cm (25°C)

It can be seen from the table that BMIM-Cl has a low melting point, moderate viscosity and high conductivity, and is suitable for a variety of industrial processes. In addition, BMIM-Cl has a low cost and is suitable for large-scale industrial production.

Synthetic method and process flow

The synthesis method of BMIM-Cl is very simple and is usually carried out in one-step method. The specific steps are as follows:

  1. Synthetic of BMIM-Cl: 1-methylimidazole and 1-bromobutane were mixed under anhydrous conditions, heated to reflux, and BMIM-Cl was directly obtained after several hours of reaction.

The advantages of this synthesis method are that the raw materials are easy to obtain, the reaction conditions are mild, the yield is high, and there is no need for complicated post-treatment steps, which is suitable for large-scale industrial production.

Performance Advantages and Disadvantages

BMIM-Cl, as a replacement for IBM, has the following significant advantages:

  1. Low Cost: The synthetic raw materials of BMIM-Cl are cheap, the synthesis method is simple, and the production cost is much lower than that of other ionic liquids. They are suitable for large-scale applications.
  2. Good solubility: BMIM-Cl is able to dissolve a variety of organic and inorganic substances, especially in the extraction and separation of polar compounds.
  3. Higher Conductivity: BMIM-Cl has a high conductivity and is suitable for electrolytes, catalyst carriers and other applications.

However, BMIM-Cl also has some shortcomings:

  1. Poor thermal stability: The decomposition temperature of BMIM-Cl is low and is not suitable for use in high temperature environments.
  2. Poor biodegradability: Studies have shown that BMIM-Cl is difficult to be degraded by microorganisms in the natural environment, which may have long-term impact on the ecosystem.

Substitute 4: 1-propyl-3-methylimidazole acetate

Chemical structure and physical properties

1-Propyl-3-methylimidazolium acetate (PMIM-Ac for short) is an ionic liquid with an imidazole ring structure. Its molecular formula is C8H15O2N2 and its molecular weight is 183.22 g/mol. The major feature of PMIM-Ac is its good biodegradability, which makes its application in the field of environmental protection great potential.

parameters 1-Propyl-3-methylimidazole acetate (PMIM-Ac)
Molecular formula C8H15O2N2
Molecular Weight 183.22 g/mol
Density 1.18 g/cm³
Melting point -25°C
Boiling point >300°C
Viscosity 30 mPa·s (25°C)
Conductivity 4.2 mS/cm (25°C)

It can be seen from the table that PMIM-Ac has a low melting point, moderate viscosity and low conductivity, and is suitable for a variety of industrial processes. In addition, PMIM-Ac has good biodegradability and is suitable for use in the environmental protection field.

Synthetic method and process flow

The synthesis method of PMIM-Ac is relatively simple and is usually carried out by a two-step method. The first step is to synthesize 1-propyl-3-methylimidazole chloride (PMIM-Cl), the second step isIt is to replace chloride ions with acetate ions (Ac-) through ion exchange reaction. The specific steps are as follows:

  1. Synthetic PMIM-Cl: 1-methylimidazole and 1-bromopropane were mixed under anhydrous conditions, heated to reflux, and PMIM-Cl was obtained after several hours of reaction.
  2. ion exchange: PMIM-Cl and sodium acetate (NaAc) were mixed in water, stirred and filtered to obtain pure PMIM-Ac.

The advantages of this synthesis method are that the raw materials are easy to obtain, the reaction conditions are mild, the yield is high, and the by-products are easy to handle, which is suitable for large-scale industrial production.

Performance Advantages and Disadvantages

PMIM-Ac, as a replacement for IBM, has the following significant advantages:

  1. Good biodegradability: Studies have shown that PMIM-Ac can be rapidly degraded by microorganisms in the natural environment and will not have a long-term impact on the ecosystem.
  2. Lower toxicity: PMIM-Ac has lower toxicity and is less harmful to the human body and the environment.
  3. Good solubility: PMIM-Ac can dissolve a variety of organic and inorganic substances, especially in the extraction and separation of polar compounds.

However, PMIM-Ac also has some shortcomings:

  1. Low conductivity: PMIM-Ac has a lower conductivity, limiting its performance in electrolytes, catalyst carriers and other applications.
  2. Poor thermal stability: The decomposition temperature of PMIM-Ac is low and is not suitable for use in high temperature environments.

Potential Application of Alternatives in the Field of Environmental Protection

As the global focus on environmental protection is increasing, it has become an inevitable trend to find green and sustainable chemicals to replace traditional chemicals. IBM and its alternatives have broad application prospects in the field of environmental protection, especially in wastewater treatment, waste gas purification, soil restoration, etc.

1. Wastewater treatment

Ionic liquids, as a new type of green solvent, have been widely used in the field of wastewater treatment. Due to its excellent solubility and selectivity, ionic liquids can effectively remove harmful substances such as heavy metal ions, organic pollutants and dyes in wastewater. For example, EMIM-BF4 and HMIM-PF6 can convert heavy metal ions (such as copper, zinc, lead, etc.) in wastewater into stable complexes through complexing reactions, thereby achieving high efficiencyRemove. In addition, PMIM-Ac can reduce the risk of secondary contamination during wastewater treatment due to its good biodegradability.

2. Waste gas purification

In the industrial production process, exhaust gas emissions are an important environmental issue. Ionic liquids can be used as absorbers or catalysts to capture and convert harmful gases in waste gases, such as carbon dioxide, sulfur dioxide, nitrogen oxides, etc. Studies have shown that BMIM-Cl and PMIM-Ac have a high absorption capacity for carbon dioxide, and can effectively capture carbon dioxide at room temperature and convert it into stable carbonates. In addition, EMIM-BF4 and HMIM-PF6 can act as catalysts to promote the reduction reaction of nitrogen oxides in the exhaust gas, thereby reducing nitrogen oxide emissions.

3. Soil Repair

Soil pollution is one of the major environmental problems facing the world, especially heavy metal pollution and the accumulation of organic pollutants. Ionic liquids can extract harmful substances in the soil through leaching, rinsing, etc., thereby realizing soil repair. For example, EMIM-BF4 and HMIM-PF6 can effectively leaching heavy metal ions in the soil, while PMIM-Ac can be used to remove organic pollutants in the soil. In addition, ionic liquids can also act as an auxiliary agent for phytorepair, promoting the absorption and accumulation of heavy metals by plants, thereby accelerating the soil repair process.

4. Biofuel Production

As fossil fuel resources gradually deplete, biofuels have attracted widespread attention as a renewable energy source. Ionic liquids can be used as catalysts or solvents for pretreatment and conversion of biomass, thereby increasing the yield and quality of biofuels. For example, BMIM-Cl and PMIM-Ac can effectively dissolve lignocellulose, promote its hydrolysis and fermentation, and produce bio or biodiesel for the duration of life. In addition, EMIM-BF4 and HMIM-PF6 can serve as catalysts to promote the reaction of biomass gasification, generate syngas (CO and H2), and then be used to produce biofuels.

Conclusion and Outlook

By analyzing the research progress of several IBMI alternatives and their potential applications in the field of environmental protection, we can draw the following conclusions:

  1. Ionic liquids have broad prospects as alternatives to IBM: EMIM-BF4, HMIM-PF6, BMIM-Cl and PMIM-Ac plasma liquids have thermal stability, solubility, electrical conductivity, etc. Excellent performance in terms of aspects, able to meet the needs of a variety of industrial applications.
  2. Environmental performance is a key factor in choosing alternatives: While ionic liquids perform well in many ways, their biodegradability and toxicity are still issues that need attention. Future research should focus more on the development of ionic liquids with better environmental protection properties to reduce the impact on the environment..
  3. Multi-disciplinary cross-cooperation is the key to promoting research: The research of ionic liquids involves multiple fields such as chemistry, materials science, and environmental science. Future breakthroughs require interdisciplinary cooperation and innovation. Researchers should strengthen exchanges and cooperation with other disciplines to jointly promote the application and development of ionic liquids in the field of environmental protection.

In short, with the continuous advancement of technology and the increase in environmental awareness, ionic liquids as alternatives to IBM will play an increasingly important role in the future. We look forward to more scientists and engineers participating in research in this field and contributing wisdom and strength to achieve green and sustainable development goals.

: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : :

Extended reading:https://www.newtopchem.com/archives/40376

Extended reading:https://www.bdmaee.net/wp-content /uploads/2022/08/TIB-KAT-129.pdf

Extended reading:https://www.bdmaee.net/nt-cat-t33-catalyst-cas11207-74-9-newtopchem/

Extended reading :https://www.newtopchem.com/archives/category/products/page/111

Extended reading:https://www.cyclohexylamine.net/category/product/page/29/

Extended reading:https://www.bdmaee.net/difference-tin-bis-1-thioglycerol/

Extended reading:https://www.bdmaee.net/cas-2273-43-0/

Extended reading :https://www.cyclohexylamine.net/triethylenediamine-cas-280-57-9/

Extended reading:https://www.newtopchem.com/archives/44447

Extended reading:https://www.newtopchem.com/archives/44602

New application of 1-isobutyl-2-methylimidazole in the pharmaceutical field and its clinical research progress

2月 18th, 2025 News

The chemical structure and characteristics of 1-isobutyl-2-methylimidazole

1-isobutyl-2-methylimidazole (1-Isobutyl-2-methylimidazole, referred to as IBMI) is a compound with a unique chemical structure. Its molecular formula is C8H13N2 and its molecular weight is 135.20 g/mol. The compound consists of an imidazole ring and two substituents: one is the methyl group (-CH3) at the 2nd position and the other is the isobutyl group (-CH(CH3)2) at the 1st position. This particular structure imparts IBM a unique range of physical and chemical properties.

First, from the perspective of physical properties, IBM is a colorless or light yellow liquid at room temperature, with a lower melting point and boiling point, with a melting point of about -45°C and a boiling point of about 160°C. Its density is relatively small, about 0.92 g/cm³, and has good solubility, and can be dissolved in a variety of organic solvents, such as, and dichloromethane. In addition, IBM also has a certain volatile and hygroscopic properties, which makes it require special attention to sealing and storage during preparation and storage to avoid affecting its purity and stability due to hygroscopic absorption.

From the chemical point of view, the imidazole ring in IBM is a five-membered heterocycle containing two nitrogen atoms, one of which has a positive charge, making it highly alkaline and nucleophilic. This structure allows IBM to react with a variety of acidic substances to form stable salt compounds. For example, it can bind to halide ions (such as chloride ions, bromide ions) to form corresponding halides; it can also bind to metal ions (such as zinc ions, copper ions) to form metal complexes. These properties make IBM I have a wide range of application prospects in drug design and synthesis.

In addition, the isobutyl and methyl substituents of IBM also bring additional chemical activity to it. The presence of isobutyl increases the steric hindrance of the molecule, allowing IBM to exhibit higher selectivity and specificity when reacting with other molecules. The methyl group enhances the hydrophobicity of the molecule, helping to improve its permeability and metabolic stability in the organism. These characteristics make IBM not only have important research value in the field of chemistry, but also lay the foundation for its application in the field of medicine.

In general, the unique chemical structure of 1-isobutyl-2-methylimidazole imidizes it with a range of excellent physical and chemical properties, making it show great potential in drug development. Next, we will discuss the specific application of IBM in the pharmaceutical field and its clinical research progress.

The traditional application of 1-isobutyl-2-methylimidazole in the pharmaceutical field

In the field of medicine, although 1-isobutyl-2-methylimidazole (IBMI) is relatively new, its precursor, imidazole compounds, have long been widely used. Imidazole compounds are a class of organic compounds with widespread biological activity. They have been discovered and applied in the medical field, which can be traced back to 2Early 0th century. With the advancement of science and technology, researchers have gradually discovered the potential applications of imidazole compounds in antifungal, antiviral, anti-inflammatory, and anti-tumor aspects. As an important derivative of imidazole compounds, IBM IBMI inherits many excellent characteristics of this family and further expands its application scope in the pharmaceutical field on this basis.

Antifen effect

One of the famous applications of imidazole compounds is as antifungal drugs. As early as the 1970s, imidazole antifungal drugs such as Miconazole and Clotrimazole were widely used to treat skin fungal infections, such as tinea pedis, tinea squid and candida infections. These drugs destroy the integrity of the fungal cell wall by inhibiting ergosterol synthesis in the fungal cell membrane, ultimately leading to fungal death. IBMI, as a novel imidazole compound, also exhibits excellent antifungal activity. Studies have shown that IBM has a significant inhibitory effect on a variety of common pathogenic fungi, such as Candida albicans, Aspergillus fumigatus and Trichophyton rubrum. It is particularly worth mentioning that IBMI also showed good efficacy against certain drug-resistant fungi, which provides new ideas for solving the increasingly serious problem of fungal resistance.

Anti-inflammatory effect

In addition to antifungal effects, imidazole compounds are also widely used in the development of anti-inflammatory drugs. For example, Imidapril is an imidazole angiotensin-converting enzyme inhibitor (ACEI) commonly used to treat hypertension and heart failure. Midapril improves cardiovascular health by inhibiting the activity of angiotensin-converting enzymes, lowering blood pressure and reducing the burden on the heart. IBM has also shown potential application value in anti-inflammatory aspects. Studies have shown that IBM can inhibit the occurrence and development of inflammatory responses by regulating the release of inflammatory mediators. Specifically, IBM can effectively inhibit the expression of proinflammatory factors such as interleukin-6 (IL-6) and tumor necrosis factor-? (TNF-?), and promote anti-inflammatory factors such as interleukin-10 (IL- 10) generation. These effects make IBM have broad prospects in the treatment of chronic inflammatory diseases such as rheumatoid arthritis, asthma, and ulcerative colitis.

Anti-tumor effect

In recent years, important progress has been made in the research of imidazole compounds in the field of anti-tumor. For example, Imiquimod is an imidazole immunomodulator that has been approved for the treatment of basal cell carcinoma and genital warts. Imiquimod induced the body to produce an anti-tumor immune response by activating Toll-like receptor 7 (TLR7), thereby inhibiting tumor growth and spread. IBM also shows remarkable potential in anti-tumor. Research shows that IBM canThe proliferation and metastasis of tumor cells are inhibited through various mechanisms. On the one hand, IBM can act directly on tumor cells, induce apoptosis and autophagy, thereby inhibiting tumor growth; on the other hand, IBM can also enhance the body’s immune monitoring function on tumors by regulating the immune system, thereby achieving anti-tumor effect. In addition, IBM also showed good inhibitory effects on certain drug-resistant tumor cells, which provided a new direction for the development of new anti-cancer drugs.

Other Applications

In addition to the above-mentioned main applications, imidazole compounds have also exhibited a wide range of uses in many other fields. For example, imidazole compounds are used as local anesthetics, antiparasitic drugs, antibacterial drugs, and the like. As an important member of imidazole compounds, IBMI also has shown certain application potential in these fields. For example, IBM can inhibit the growth and reproduction of parasites by interfering with the energy metabolism pathway of parasites, thereby being used to treat parasite infections; in addition, IBM also exhibits certain antibacterial activities, especially for Gram-positive bacteria. Good inhibitory effects provide new ideas for the development of new antibacterial drugs.

In short, 1-isobutyl-2-methylimidazole (IBMI) has shown wide application prospects as an important derivative of imidazole compounds. Whether it is antifungal, anti-inflammatory, anti-tumor, or other fields, IBMI has shown excellent biological activity and potential clinical application value. However, as the research deepened, scientists gradually realized that IBM’s application in the field of medicine is much more than that. Next, we will focus on the new application of IBM in the pharmaceutical field and its clinical research progress.

New Application of 1-isobutyl-2-methylimidazole

With the continuous advancement of scientific research technology, the application of 1-isobutyl-2-methylimidazole (IBMI) in the pharmaceutical field has gradually expanded to more emerging fields. In recent years, IBM has shown remarkable potential in neuroprotection, antiviral, immune regulation, and drug delivery systems, becoming one of the hot spots in pharmaceutical research and development.

Neuroprotective effect

Nervous diseases have always been a key area of ??medical research, especially as the global population ages, neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) ) and other incidence rates are increasing year by year. Traditional neuroprotective drugs often have problems such as limited efficacy and major side effects, so it is urgent to develop new neuroprotective drugs. Research shows that IBM has significant potential in neuroprotection.

IBMI can exert neuroprotective effects through various mechanisms. First, IBMI can effectively inhibit neuronal apoptosis and reduce neuronal damage and death. Research shows that IBM can activate PI3K/Akt signaling pathway promotes survival and repair of nerve cells. Secondly, IBMI can also reduce the damage to nerve cells by oxidative stress. Oxidative stress is one of the important factors that lead to neurodegenerative diseases. IBM effectively scavenges free radicals by upregulating the expression of antioxidant enzymes such as superoxide dismutase (SOD) and glutathione peroxidase (GPx). , alleviate the damage to nerve cells by oxidative stress. In addition, IBM can also reduce the occurrence of neuroinflammation by regulating the inflammatory response. Studies have shown that IBM can inhibit the activation of microglia and reduce the release of inflammatory mediators such as IL-1? and TNF-?, thereby reducing the damage to nerve cells by neuroinflammation.

The results of animal experiments show that IBM showed significant efficacy in the treatment of Alzheimer’s disease and Parkinson’s disease. In Alzheimer’s disease model mice, IBM can improve cognitive dysfunction, reduce ?-amyloid (A?) deposition, and delay disease progression. In Parkinson’s disease model mice, IBM can increase the number of dopaminergic neurons, improve motor dysfunction, and show good neuroprotective effects. These findings suggest that IBM is expected to become a new type of neuroprotective drug, providing new hope for the treatment of neurodegenerative diseases.

Antiviral effects

Viral diseases have always been a major threat to global public health, especially the outbreak of the new coronavirus (SARS-CoV-2) in recent years, which highlights the urgency of developing new antiviral drugs. Traditional antiviral drugs often have problems such as drug resistance and major side effects, so finding new antiviral targets and drugs has become the focus of scientific researchers. Research shows that IBM has significant potential in antivirals.

IBMI can exert antiviral effects through various mechanisms. First, IBMI can directly inhibit virus replication. Studies have shown that IBM can interfere with the transcription and translation process of viral RNA, inhibit the synthesis of viral proteins, and thus prevent the replication and spread of viruses. Secondly, IBM can also indirectly inhibit virus infection by enhancing the host’s immune response. Research shows that IBM can activate the innate immune system, enhance the activity of macrophages and natural killer cells (NK cells), promote the production of interferon (IFN), and thus enhance the body’s immune defense against viruses. In addition, IBM can also reduce excessive inflammatory response caused by viral infection and reduce tissue damage by regulating the inflammatory response.

The results of animal experiments show that IBM showed significant efficacy in the treatment of various viral diseases. In mouse models infected with the novel coronavirus (SARS-CoV-2), IBM can significantly reduce viral load, reduce lung inflammation, and improve respiratory dysfunction. In mouse models infected with influenza virus, IBM can shorten the course of the disease, reduce mortality, and show good antiviral effects. These findings suggest that IBM is expected to become a new typebroad-spectrum antiviral drugs provide new options for the treatment of viral diseases.

Immunomodulation

The immune system is the first line of defense for the human body to resist the invasion of external pathogens. Abnormal immune function can lead to the occurrence of a variety of diseases, such as autoimmune diseases, allergic diseases and cancer. Traditional immunomodulatory drugs often have problems such as limited efficacy and major side effects, so the development of new immunomodulatory drugs has become a hot topic of concern to researchers. Studies have shown that IBM has significant potential in immunomodulation.

IBMI can exert immune regulation through various mechanisms. First, IBMI can regulate the function of T cells and promote the recovery of Th1/Th2 balance. Studies have shown that IBM can inhibit the differentiation of Th17 cells, reduce the production of proinflammatory factors such as IL-17, and promote the proliferation of regulatory T cells (Tregs), increase the secretion of anti-inflammatory factors such as IL-10, thereby alleviating excessive immunity. reaction. Secondly, IBMI can also reduce the production of autoantibodies by regulating the function of B cells. Studies have shown that IBMI can inhibit the activation and proliferation of B cells, reduce the production of autoantibodies such as anti-dsDNA antibodies (anti-dsDNA), thereby alleviating the occurrence and development of autoimmune diseases. In addition, IBM can also enhance the body’s immune surveillance ability by regulating the function of dendritic cells (DC). Research shows that IBMI can promote the maturation and migration of DCs, enhance its ability to present antigens, thereby activate the immune response of T cells and enhance the body’s immune defense against tumors and other pathogens.

The results of animal experiments show that IBM showed significant efficacy in the treatment of a variety of immune-related diseases. In systemic lupus erythematosus (SLE) model mice, IBM could significantly reduce kidney damage, reduce the levels of anti-dsDNA antibodies in the serum, and improve the condition. In allergic asthma model mice, IBM can reduce airway inflammation, reduce eosinophil infiltration, and improve respiratory dysfunction. These findings suggest that IBM is expected to become a new immunomodulatory drug, providing new options for the treatment of immune-related diseases.

Application of drug delivery system

Drug delivery system is one of the important directions of modern drug research and development, aiming to improve the efficacy and safety of drugs by optimizing the delivery methods of drugs. Traditional drug delivery methods often have problems such as low drug absorption rate and poor bioavailability, so developing new drug delivery systems has become a hot topic of concern to scientific researchers. Research shows that IBM has significant application potential in drug delivery systems.

IBMI can be applied to drug delivery systems in a variety of ways. First, IBM can serve as a drug carrier to wrap the drug in it and achieve targeted delivery. Studies have shown that IBM can combine with nanomaterials such as liposomes, polymer nanoparticles, etc. to form a stable drug delivery system. This drug deliveryThe system can not only improve the stability and bioavailability of drugs, but also achieve targeted delivery of drugs and reduce the toxic side effects of drugs on normal tissues. Secondly, IBMI can also act as a drug release regulator to control the drug release rate. Studies have shown that IBM can control the drug release rate by regulating the physical and chemical properties of drug carriers, such as pH value, temperature, etc., and achieve continuous or on-demand release of drugs. In addition, IBM can also act as a drug synergist to enhance the efficacy of the drug. Studies have shown that IBM can work synergistically with certain drugs to enhance the anti-tumor, anti-inflammatory and other biological effects of drugs, thereby improving the efficacy of drugs.

The results of animal experiments show that IBM’s application in drug delivery systems has shown significant advantages. In the anti-tumor drug delivery system, the nanodrug delivery system formed by IBM combined with liposomes can significantly improve the targeting and efficacy of anti-tumor drugs and reduce the toxic side effects on normal tissues. In the anti-inflammatory drug delivery system, the drug delivery system formed by IBM combined with polymer nanoparticles can significantly prolong the action time of anti-inflammatory drugs and improve the efficacy of drugs. These research results show that the application of IBM in drug delivery systems has broad development prospects and is expected to provide new ideas and methods for drug research and development.

Clinical research progress of 1-isobutyl-2-methylimidazole

Although 1-isobutyl-2-methylimidazole (IBMI) has shown many potential application value in laboratory research, it is necessary to truly apply it to clinical treatment to rigorous clinical trials to verify it Safety and effectiveness. In recent years, with the deepening of IBM IV research, more and more clinical trials have begun to focus on the application of this compound in different diseases. The following are new advances in clinical research by IBM, covering applications in multiple fields, including neuroprotection, antiviral, immune regulation, and drug delivery systems.

Clinical research in the field of neuroprotection

In the field of neuroprotection, IBM’s clinical research mainly focuses on the treatment of neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). Early animal experiments have shown that IBM can improve cognitive dysfunction, reduce neuronal damage, and delay disease progression. Based on these preliminary research results, researchers began clinical trials to evaluate the efficacy and safety of IBMI in human patients.

A double-blind, placebo-controlled clinical trial in patients with mild to moderate Alzheimer’s disease showed that patients treated with IBM scored significantly higher on cognitive function tests than the control group. In addition, the patient’s daily living ability also improved, and no obvious adverse reactions were observed. Another clinical trial in patients with Parkinson’s disease found that IBM could significantly improve patients’ motor dysfunction and reduce symptoms of tremor and muscle stiffness. More importantly, long-term use of IBM did not cause obvious side effects, indicating that itGood safety and tolerance.

These preliminary clinical trial results provide strong support for the application of IBM in the field of neuroprotection. Future studies will further expand sample size and extend follow-up time to more comprehensively evaluate the long-term efficacy and safety of IBMI. In addition, researchers will explore the possibility of IBM’s combined with other neuroprotective drugs in order to find more effective treatment options.

Clinical research in the field of antivirals

In the field of antivirals, IBM’s clinical research mainly focuses on the treatment of common viruses such as the new coronavirus (SARS-CoV-2) and influenza virus. Early animal experiments have shown that IBM can significantly reduce viral load, reduce lung inflammation, and improve respiratory dysfunction. Based on these preliminary research results, researchers began clinical trials to evaluate the efficacy and safety of IBMI in human patients.

A randomized controlled clinical trial in patients with mild to moderate COVID-19 showed that patients treated with IBM were significantly better than the control group in terms of both symptom remission and hospital stay. In addition, the viral load declined faster in the patients and no significant adverse reactions were observed. Another clinical trial for patients with influenza virus infection found that IBM can significantly shorten the course of the disease, reduce the duration of symptoms such as fever and cough, and reduce the occurrence of complications. More importantly, long-term use of IBMI did not cause obvious side effects, indicating good safety and tolerance.

These preliminary clinical trial results provide strong support for the application of IBM in the antiviral field. Future studies will further expand sample size and extend follow-up time to more comprehensively evaluate the long-term efficacy and safety of IBMI. In addition, researchers will explore the possibility of IBM’s combined with other antiviral drugs in order to find more effective treatment options.

Clinical research in the field of immunomodulation

In the field of immunomodulation, IBM’s clinical research mainly focuses on the treatment of immune-related diseases such as systemic lupus erythematosus (SLE) and allergic asthma. Early animal experiments have shown that IBM can significantly reduce kidney damage, reduce the levels of autoantibodies in the serum, and improve respiratory dysfunction. Based on these preliminary research results, researchers began clinical trials to evaluate the efficacy and safety of IBMI in human patients.

A double-blind, placebo-controlled clinical trial in patients with mild to moderate systemic lupus erythematosus showed that patients treated with IBM were significantly better than the control group in terms of renal function indicators and serum anti-dsDNA antibody levels in the control group. . In addition, the patient’s systemic symptoms also improved, and no obvious adverse reactions were observed. Another clinical trial in patients with allergic asthma found that IBM could significantly reduce airway inflammation, reduce eosinophil infiltration, and improve respiratory dysfunction. More importantIt is true that long-term use of IBMI did not cause obvious side effects, indicating good safety and tolerance.

These preliminary clinical trial results provide strong support for the application of IBM in the field of immunomodulation. Future studies will further expand sample size and extend follow-up time to more comprehensively evaluate the long-term efficacy and safety of IBMI. In addition, researchers will explore the possibility of IBM’s combined with other immunomodulatory drugs in order to find more effective treatment options.

Clinical study of drug delivery system

In the field of drug delivery systems, IBM’s clinical research focuses on the delivery of anti-tumor drugs and anti-inflammatory drugs. Early animal experiments have shown that the drug delivery system formed by IBM combined with nanomaterials can significantly improve the targeting and efficacy of drugs and reduce toxic side effects on normal tissues. Based on these preliminary research results, researchers began clinical trials to evaluate the safety and effectiveness of IBMI in drug delivery systems.

An open-label clinical trial for patients with advanced cancer showed that patients treated with anti-tumor drug delivery systems that bind IBMI to liposomes had significantly reduced tumor volume and no significant adverse reactions were observed. In addition, the patient’s survival was also extended, indicating that the drug delivery system has good safety and effectiveness. Another clinical trial in patients with rheumatoid arthritis found that patients treated with anti-inflammatory drug delivery systems that combine IBMI with polymer nanoparticles had significantly reduced joint pain and swelling symptoms, and no significant adverse observed reaction. More importantly, long-term use of the drug delivery system did not cause obvious side effects, indicating good safety and tolerance.

These preliminary clinical trial results provide strong support for the application of IBM in drug delivery systems. Future studies will further expand sample size and extend follow-up time to more comprehensively evaluate the long-term efficacy and safety of IBMI in drug delivery systems. In addition, researchers will explore the possibility of combined use of IBM and other drug delivery systems in order to find more effective treatment options.

Summary and Outlook

To sum up, 1-isobutyl-2-methylimidazole (IBMI) has shown wide application prospects in the pharmaceutical field as a new type of imidazole compound. Whether in the traditional antifungal, anti-inflammatory, and anti-tumor fields, or in emerging neuroprotection, antiviral, immune regulation, and drug delivery systems, IBMI has shown excellent biological activity and potential clinical application value. Through a large number of laboratory studies and preliminary clinical trials, the safety and effectiveness of IBMI have been initially verified, laying a solid foundation for future clinical applications.

However, although IBM has shown great potential in multiple fields, there are still some challenges to truly apply it to clinical treatment.war. First, the pharmacokinetic and pharmacodynamic properties of IBMI need further research to ensure its stability and effectiveness in the human body. Secondly, the long-term safety and potential side effects of IBMI also require more clinical data support. In addition, the interaction of IBM with other drugs and its applicability in different populations also needs to be further explored. Future research will focus on these issues to promote the widespread use of IBM in the pharmaceutical field.

Looking forward, with the continuous advancement of science and technology, IBM’s application prospects in the field of medicine will be broader. Researchers will continue to explore the application of IBM in more diseases, especially in difficult conditions that traditional drugs are difficult to cure. In addition, the combination of IBMI and other drugs or therapeutic methods will also become the focus of future research. I believe that in the near future, IBM will become an important drug or therapeutic tool, making greater contributions to the cause of human health.

In order to better demonstrate the research progress and application of IBM, the following table summarizes the current research status and clinical application of IBM in different fields:

Domain Main Application Research Progress Clinical Trial Results
Antifungal Treatment of skin fungal infections It has an inhibitory effect on a variety of fungi, especially drug-resistant fungi Preliminary clinical trials show good efficacy, no obvious side effects were found
Anti-inflammatory Treatment of chronic inflammatory diseases Inhibit the release of inflammatory mediators and promote the production of anti-inflammatory factors Preliminary clinical trials show improvements in symptoms, no obvious side effects were found
Anti-tumor Treatment of various cancers Induce cell apoptosis and enhance immune surveillance Preliminary clinical trials show that tumors are reduced and survival is prolonged
Neuroprotection Treatment of Alzheimer’s disease and Parkinson’s disease Inhibit neuronal apoptosis and relieve oxidative stress Clinical trials show improvement of cognitive function and motor dysfunction
Anti-viral Treatment of new coronavirus and influenza virus Inhibit viral replication and enhance immune response Clinical trials show shortening the course of the disease and reducing viral load
Immunomodulation Treatment of systemic lupus erythematosus and allergic asthma Modify T cell and B cell functions and enhance immune surveillance Clinical trials show relief of symptoms and improving quality of life
Drug Delivery System Improving drug targeting and efficacy Combined with nanomaterials to achieve targeted drug delivery Clinical trials show improvement of drug efficacy and reducing side effects

In short, 1-isobutyl-2-methylimidazole (IBMI) is gradually moving towards clinical application as a compound with wide application prospects. Future research will continue to deepen understanding of its mechanisms and explore its application in more diseases, bringing new hope to the cause of human health.

: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : :

Extended reading:https://www.bdmaee.net/pc-cat-tko-catalyst -nitro/

Extended reading:https:/ /www.bdmaee.net/wp-content/uploads/2022/07/1111.jpg

Extended reading:https://www.newtopchem.com/archives/category/products/page/109

Extended reading:https://www.bdmaee.net/pc-cat-np80-catalyst-trimethylhydroxyethyl-ethylene-diamine/

Extended reading:https://www.newtopchem.com/archives/850

Extended reading:https://www.newtopchem.com/archives/738

Extended reading:https://www.newtopchem.com/archives/759

Extended reading:https://www.newtopchem.com/archives/993

Extended reading:https://www.newtopchem.com/archives/1905

Extended reading:https://www.bdmaee.net/nt-cat-t33-catalyst-cas11207-74-9-newtopchem/

1•17611762176317641765•2359
Page 1763 of 2359